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Abstract
In this article, we review the neurophysiology of the bladder and the lower urinary tract function and discuss logical concepts for 
the development of novel drug therapy for patients with lower urinary tract dysfunction.
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POINT OF VIEW
Almost 100 years ago, the fundamental study on bladder 
innervation was published by Dr. Mueller [1]. Many modern 
researchers studying the physiological process of micturition 
rely upon this classic work, which is both logical and lucid 
[2,3]. However, some points need to be adapted to fit the latest 
developments in medical science. There are objective reasons for 
further investigation. 
Why do drugs causing the autonomic denervation of the 
lower urinary tract (LUT) improve the micturition process [2, 4, 
5]? How does the LUT deprived of external neural control restore 
the ability to perform adequate micturition [2, 6]? The answers 
can be objectively formulated only on one assumption. Initially, 
the LUT is able to perform the autonomous operation. The 
potency to possess such autonomy is retained throughout life and 
is manifested in the suppression of abnormal neural regulation 
from the outside.
From personal experience of cadaveric kidney 
transplantation, we have observed the implementation of such 
autonomy in the upper urinary tract. Sensing the internal urine 
flow in the denervated renal-ureteral transplant appears sufficient 
to trigger adequate urine flow to the bladder. The question that 
arises is whether the LUT is able to complete this process without 
the intervention of the nervous impulses from the outside. 
The binary regulation of the LUT functions, in our view, is an 
acceptable concept to the explanation of the action of modern 
drugs with proven efficacy in the treatment of LUT dysfunction 
(Fig.1).
It is known that a well-coordinated function of the LUT is 
controlled by the nervous system (NS). The activation of a certain 
NS level determines the functional state of the LUT. The urine 
retention process is regulated mainly by the sympathetic nervous 
system (SNS). The conscious feeling of bladder fullness is 
mediated by the bladder wall dilatation against the background of 
the increase in urine volume in the filling phase. In this situation, 
the afferent impulses from the bladder wall receptors are 
conducted to the sacral spinal cord via the pelvic parasympathetic 
nerves. Further, they are conducted to the micturition center 
located in the pons and the cortex [2, 3, 7].
The brain contains the external control centers that assess 
the current situation. If there is an acceptable situation for a 
particular individual, the brain, sensing the urge for micturition, 
triggers the start of urination via concrete action. Simultaneously, 
the rectus abdominis muscles innervated by the intercostal nerves 
are gently strained, while the perineal muscles are relaxed, in 
response to the somatic afferent impulses, which reach the target 
via the pudendal nerve. This is the conscious and controlled stage 
of external micturition control. Further, the somatic impetus 
inhibits the sympathetic dominance, which provides for slow 
accumulation and storage of urine; next, the parasympathetic 
influence on the bladder via the efferent pathways of the pelvic 
nerves increases which, in turn, allows for rapid and complete 
emptying of the bladder. This is the second or vegetative stage 
of the external control of the micturition act [1, 8]. The next step 
will be to identify the way the autonomic nervous system (ANS) 
performs the internal management of the LUT to perceive and 
react at this stage. Only the “owner” of the urinary tract will be 
able to accurately perceive this impact! As a result of the filling of 
the bladder with urine and stretching the myocytes, an electrical 
potential gets accumulated. This potential is the functional 
mechanism for the control of the detrusor muscle in autonomous 
bladder function. During external regulation, bladder adaptation 
*Corresponding author:  Vadim B.  Berdichevskii, PhD, Department 
of Surgery with the Urology course. Tyumen State Medical Academy.
Tyumen, Russian Federation. 
E-mail: doktor_bba@mail.ru216                              V. B. Berdichevskii & B. A. Berdichevskii / International Journal of BioMedicine 3(3) (2013) 215-216
control to urine volume, which exceeds the autonomous capability, 
is also provided with the electric potential that is accumulated 
in the myocytes resulting from the conversion of the chemical 
effects of the ANS neurotransmitters, in the electrical equivalent. 
Due to the imbalance between the chemical and the mechanical 
components, which generates this energy, various manifestations 
of LUT dysfunction can be expected. 
Thus, LUT dysfunction could be the result of the 
desynchronization between the external and internal paths of 
the control of the urination act. The search for mechanisms 
responsible for the synchronization of this process could be the 
perspective from which future studies need to be done in terms 
of developing new and effective treatments for this type of 
pathology.
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